Tim Cook steps down as Apple’s CEO on September 1, 2026, and John Ternus takes over. Many of the recaps of the Cook era will lead with the iPhone, services, and the trillions of dollars of market cap. Far fewer will take seriously the claim he made to Jim Cramer in January 2019:

“I believe, if you zoom out into the future, and you look back, and you ask the question, ‘What was Apple’s greatest contribution to mankind?’ it will be about health.”

I was on the Apple Health team then. We watched it in real time. Several of us looked at each other and asked some version of: what the heck is he talking about. The iPhone was already the most successful consumer product in human history. Cook had just set a bar above it.

With seven years of distance and an imminent handoff of the CEO job, I think I finally understand what he meant.

What he didn’t say

Cook, in that interview, said “democratizing health care” and “empowering the individual to manage their health.” The semantic detail matters. Cook never positioned Apple as a healthcare business. He positioned Apple as the force that would hand people back the keys to their own bodies.

This wasn’t just marketing; it was the structural fact of Apple’s participation in the sector. Apple never tried to become a payer, a provider network, a pharmacy, or a PBM. It never tried to build a health system. It built a sensor, an operating system, and a trusted relationship with a billion consumers, and pointed all of that at the individual.

The missing business model

I was originally hired to scale a subsidy model for the Apple Watch, the direct analog to the carrier subsidy that had fueled the iPhone. The template came from Discovery Group, the South African financial services company founded by Adrian Gore in 1992, and its Vitality program launched in 1997. Gore and his team were our partners. Vitality treated health insurance as a behavior-change platform. Members earned points and status for gym visits, healthy grocery purchases, and preventive screenings, and those points translated directly into the monthly repayment owed on an Apple Watch. Engaged members paid little or nothing. Sedentary ones paid the full retail cost over time. The insurer reduced long-run claims, the member got healthier, and the device was effectively paid for by the behavior it enabled. Discovery had proven this shared-value insurance model over two decades across dozens of markets, and the intellectual credit for the mechanic belongs to them.

We ported the template to Aetna in the United States, and then to other U.S. payers. These were real programs, with enrolled members, real data, and real ROI calculations. Not pilots.

The subsidy never scaled in the U.S. The reason wasn’t necessarily Apple’s execution, and I don’t think it was due to a flawed behavioral model. It was the industry’s economics. American healthcare has almost no long-term economics to attribute behavior change to. Members churn between plans every few years, so a payer who invests in prevention rarely captures the downstream savings. Attribution is impossible at the individual level without the kind of longitudinal infrastructure the system has never bothered to build. If Apple, with the most trusted consumer brand in the world and a product that people wore sixteen hours a day, couldn’t close the math with Aetna, nobody could.

That was the moment I understood Cook’s word choice. He wasn’t being cautious. He was being honest about where the game was. Healthcare, as a business, was not it. Health, as a direct relationship with the user, was.

Impact without a P&L

The business model didn’t scale, but the impact happened anyway. Apple had the iPhone, the Watch, the algorithms, and millions of people who trusted it enough to wear it on their body. That was sufficient.

The evidence arrived in the form of letters. “Dear Apple,” sometimes addressed to “Dear Mr. Cook.” Enough of them that Apple turned the genre into a multi-year ad campaign. Every letter was real, emails from actual users that made their way from Tim’s inbox to the Health team, passed around internally like scripture.

One of the earliest, from September 2015, was from Paul Houle Jr., a seventeen-year-old football player at Tabor Academy. After a double practice in the heat, his Apple Watch flagged a resting heart rate of 145, double his baseline. The diagnosis was rhabdomyolysis, which in his own words caused “my heart, my liver and my kidneys all to shut down.” His doctors told him he likely wouldn’t have survived practice the next morning.

That letter, and the hundreds like it that followed, inspired the teams. Apple had launched the Watch as a fashion and fitness device. The Houle letter pointed the team at something more important: the Watch as a guardian angel.

These stories weren’t accidents, and they weren’t the incidental upside of a consumer product. They came out of a structural alignment that exists almost nowhere else in the healthcare value chain.

Every other major player in healthcare has at least one incentive that isn’t aligned with the patient. Payers profit from selection. Providers bill by encounter. Pharma sells the molecule. PBMs arbitrage the formulary. EHR vendors serve the billing department. Apple was the exception. Its only incentive was to make its users’ lives better, because that is what sold more devices. The alignment produced the impact even when the business model didn’t. No competitor could copy it, because none of them were structurally allowed to.

Why the culture held

People ask how this got maintained through a decade of product launches and quarterly earnings calls. I think the answer is that Apple’s long-tenured executives felt an obligation, not a goal. Mike O’Reilly, the first physician Apple ever hired, told me more than once that what he heard from the people who had been there through the Jobs era was a sense that the company felt an obligation to use its scale to make a difference. You could feel the same thing in Jeff Williams’ engagement with the work. Health, for him, was a passion project, not a P&L.

What Apple spawned

The ecosystem story doesn’t get told cleanly. The Apple Watch legitimized the entire wearable category. HealthKit and the Health app became the de facto integration layer that most digital health companies build around. The Apple Heart Study turned a consumer device into a clinical research participant recruitment engine at a scale no academic medical center could match. A generation of companies, continuous glucose monitors, mental health apps, sleep platforms, cardiology tools, grew inside the frame Apple established. Apple’s impact on personal health is now substantially larger than anything Apple itself ships.

The AI era

Cook leaves having proven what he claimed in 2019. The AI era reopens the question of what comes next, for Apple and for the field. The Watch broke one seam, between a person and their own biosignal data. The seams ahead are larger, and more interesting. The bet I’d make is on a class of system rather than a single company: a private AI agent that represents the user rather than the payer or the provider. It would do what ChatGPT and Claude already do without asking users to hand over their queries or their health data. It would handle guidance, triage, diagnosis, coaching, and care management. And it would represent the user when they have to navigate a system that has spent decades not representing them. Apple has real structural advantages here, the device and the trust and a decade of biosignal data on the wrist, but it may not be the only candidate.

What Cook actually did

In fifteen years, Cook moved the center of gravity of personal health from the institution to the wrist. The business model never came. The impact did. The generation that grows up with this infrastructure will not remember a world in which you had to wait for a doctor to learn that something in your body was wrong.

Dear Tim: you were right about the question. You were right about the answer. The bar above the iPhone was real. You got there without the business model anyone expected.

Thank you.